Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 19651 - 19675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	WDR18	57418	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WDR18 mRNA	19p13.3	A21749
Copper	Approved Investigational	WDR20	91833	downregulated	[Disulfiram binds to Copper] which results in decreased expression of WDR20 mRNA	14q32.31	A21750
Copper	Approved Investigational	WDR26	80232	upregulated	[NSC 689534 binds to Copper] which results in increased expression of WDR26 mRNA	1q42.11-q42.12	A21749
Copper	Approved Investigational	WDR34	89891	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WDR34 mRNA	9q34.11	A21749
Copper	Approved Investigational	WDR35	57539	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WDR35 mRNA	2p24.1	A21749
Copper	Approved Investigational	WDR4	10785	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WDR4 mRNA	21q22.3	A21749
Copper	Approved Investigational	WDR76	79968	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WDR76 mRNA	15q15.3	A21749
Copper	Approved Investigational	WDR78	79819	upregulated	[NSC 689534 binds to Copper] which results in increased expression of WDR78 mRNA	1p31.3	A21749
Copper	Approved Investigational	WDR90	197335	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WDR90 mRNA	16p13.3	A21749
Copper	Approved Investigational	WIPI1	55062	upregulated	[NSC 689534 binds to Copper] which results in increased expression of WIPI1 mRNA	17q24.2	A21749
Copper	Approved Investigational	WNT10B	7480	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WNT10B mRNA	12q13.12	A21749
Copper	Approved Investigational	WSB1	26118	upregulated	[NSC 689534 binds to Copper] which results in increased expression of WSB1 mRNA	17q11.1	A21749
Copper	Approved Investigational	WT1	7490	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WT1 mRNA	11p13	A21749
Copper	Approved Investigational	WWC3	55841	upregulated	[NSC 689534 binds to Copper] which results in increased expression of WWC3 mRNA	Xp22.2	A21749
Copper	Approved Investigational	WWTR1	25937	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of WWTR1 mRNA	3q25.1	A21749
Copper	Approved Investigational	XBP1	7494	upregulated	[NSC 689534 binds to Copper] which results in increased expression of XBP1 mRNA	22q12.1	A21749
Copper	Approved Investigational	XIAP	331	upregulated	[NSC 689534 binds to Copper] which results in increased expression of XIAP mRNA	Xq25	A21749
Copper	Approved Investigational	XPA	7507	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of XPA mRNA	9q22.33	A21749
Copper	Approved Investigational	XRCC3	7517	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of XRCC3 mRNA	14q32.3	A21749
Copper	Approved Investigational	XYLT2	64132	upregulated	[Disulfiram binds to Copper] which results in increased expression of XYLT2 mRNA	17q21.33	A21750
Copper	Approved Investigational	YDJC	150223	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of YDJC mRNA	22q11.21	A21749
Copper	Approved Investigational	YIPF6	286451	upregulated	[NSC 689534 binds to Copper] which results in increased expression of YIPF6 mRNA	Xq12-q13.1	A21749
Copper	Approved Investigational	YME1L1	10730	upregulated	[NSC 689534 binds to Copper] which results in increased expression of YME1L1 mRNA	10p12.1	A21749
Copper	Approved Investigational	YOD1	55432	upregulated	[NSC 689534 binds to Copper] which results in increased expression of YOD1 mRNA	1q32.1	A21749
Copper	Approved Investigational	YPEL5	51646	upregulated	[NSC 689534 binds to Copper] which results in increased expression of YPEL5 mRNA	2p23.1	A21749

Displaying entries 19651 - 19675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability